Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on August 13, 2025
Cygnus Compliance Unveils Bold Rebrand Ahead of Five-Year Milestone, Signaling the Next Era of Growth and Impact
RegTech and advisory firm marks five years with a bold new brand identity, expanded services, and innovative solutions for global financial institutions. JERSEY CITY, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Cygnus Compliance, a leading …
Conexus Solutions, Inc. Maintains Growth Trajectory with Fourth Appearance on Inc. 5000
Conexus Solutions, Inc., proudly announces its continued inclusion on the Inc. 5000 list of the fastest-growing private companies in the United States. PRINCETON, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Conexus Solutions, Inc., a …
Houzeo Launches Save Search and Real-Time Alerts to Help New Jersey Buyers Track Homes Effortlessly
Homebuyers in New Jersey can now access saved searches and live listing alerts, enhancing efficiency in a competitive market. NEWARK, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Houzeo, America’s Real Estate Super App, recently expanded its …
Cybersecurity Governance Expert Jonathan S. Maddock of KAMTech Solutions Recently Featured on Close Up Radio
SHREWSBURY, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Executive leaders today face an overwhelming convergence of disruption, regulation, and technological complexity. KAMTech Solutions helps them regain and maintain control. Co-founded by …
Clean Air Technologies to Deliver Targeted Air-Quality Assessments for New Jersey Schools and Senior Centers
The company brings professional air analysis services to protect vulnerable populations—students and seniors—by ensuring safe, healthy indoor environments. OAK RIDGE, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Clean Air Technologies, a …
Eightfold AI Recognized as One of HR Executive Magazine’s 2025 Products of the Year
SANTA CLARA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Eightfold AI has been named to the 2025 Products of the Year list by HR Executive Magazine and the HR Technology Conference. This annual competition, widely regarded as a benchmark for innovation and …
Enovix Shareholder Third Reminder: Early Warrant Expiration Price Condition
FREMONT, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded $10.50 for seventeen …
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the …
Applied Therapeutics Reports Second Quarter 2025 Financial Results
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …
Quorum Announces Q2 2025 Results Release Date, Conference Call and Webcast Details
CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original …
LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Announced entry into an agreement to be acquired by XOMA Royalty Corporation for between $1.16 and $1.24 per share in cash, plus a contingent value right related to LAVA’s two partnered assets and unpartnered programs Consummation of acquisition expected …
Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025
AUSTIN, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that Thomas B. Pickens III, Chairman and Chief Executive Officer, and Jennifer Cañas, Chief Financial Officer, will host …
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as …
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and …
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 - - FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - …
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clinical study of NPM-115 New $10M equity financing to enable …
Orezone Gold Reports Second Quarter 2025 Results
All dollar amounts are in USD unless otherwise indicated and abbreviation “M” means million. VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX/ASX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) is pleased to report …
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market …
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
Continued advancement of two clinical-stage assets, both with clinically demonstrated single-agent anti-tumor activity -- ACR-368 in a registrational-intent Phase 2 study in endometrial cancer and ACR-2316 in a Phase 1 study in AP3-predicted tumor types …